Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
1mzn | BM6 | Retinoic acid receptor RXR-alpha |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
1mzn | BM6 | Retinoic acid receptor RXR-alpha | / | 1.000 | |
1rdt | L79 | Retinoic acid receptor RXR-alpha | / | 0.631 | |
1mvc | BM6 | Retinoic acid receptor RXR-alpha | / | 0.602 | |
4k6i | 9RA | Retinoic acid receptor RXR-alpha | / | 0.600 | |
2p1t | 3TN | Retinoic acid receptor RXR-alpha | / | 0.598 | |
1xiu | REA | Retinoic acid receptor RXR | / | 0.587 | |
1fm6 | 9CR | Retinoic acid receptor RXR-alpha | / | 0.579 | |
2p1v | 5TN | Retinoic acid receptor RXR-alpha | / | 0.579 | |
4m8h | R4M | Retinoic acid receptor RXR-alpha | / | 0.570 | |
1xls | REA | Retinoic acid receptor RXR-alpha | / | 0.567 | |
1k74 | 9CR | Retinoic acid receptor RXR-alpha | / | 0.565 | |
3oap | REA | Retinoic acid receptor RXR-alpha | / | 0.559 | |
2p1u | 4TN | Retinoic acid receptor RXR-alpha | / | 0.555 | |
4m8e | 29V | Retinoic acid receptor RXR-alpha | / | 0.553 | |
1fby | REA | Retinoic acid receptor RXR-alpha | / | 0.552 | |
3fal | REA | Retinoic acid receptor RXR-alpha | / | 0.549 | |
3uvv | REA | Retinoic acid receptor RXR-alpha | / | 0.537 | |
3fc6 | REA | Retinoic acid receptor RXR-alpha | / | 0.533 | |
2acl | REA | Retinoic acid receptor RXR-alpha | / | 0.531 | |
4k4j | 1O8 | Retinoic acid receptor RXR-alpha | / | 0.531 | |
1uhl | MEI | Retinoic acid receptor RXR-beta | / | 0.530 | |
1fm9 | 9CR | Retinoic acid receptor RXR-alpha | / | 0.529 | |
2y98 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.475 | |
2gjn | FMN | Nitronate monooxygenase | 1.13.12.16 | 0.470 | |
3up0 | D7S | aceDAF-12 | / | 0.469 | |
2hk9 | NAP | Shikimate dehydrogenase (NADP(+)) | / | 0.466 | |
2uxo | TAC | HTH-type transcriptional regulator TtgR | / | 0.465 | |
3gbk | 2PQ | Peroxisome proliferator-activated receptor gamma | / | 0.465 | |
3zoi | M2W | Isopenicillin N synthase | 1.21.3.1 | 0.464 | |
4lxj | LAN | Lanosterol 14-alpha demethylase | 1.14.13.70 | 0.464 | |
3a1l | 2CC | Cytochrome P450 | / | 0.462 | |
4jvb | 1M0 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.462 | |
2jc6 | QPP | Calcium/calmodulin-dependent protein kinase type 1D | 2.7.11.17 | 0.461 | |
2ydo | ADN | Adenosine receptor A2a | / | 0.460 | |
3q0g | BCO | Probable enoyl-CoA hydratase echA8 | 4.2.1.17 | 0.459 | |
1bk0 | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.458 | |
2xvw | 9NR | Serum albumin | / | 0.458 | |
1g3m | PCQ | Estrogen sulfotransferase | 2.8.2.4 | 0.457 | |
4jlj | 1NM | Deoxycytidine kinase | 2.7.1.74 | 0.456 | |
1w06 | W05 | Isopenicillin N synthase | 1.21.3.1 | 0.455 | |
2e0n | SAH | Precorrin-2 C20-methyltransferase | / | 0.455 | |
3iro | 2CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.454 | |
5bn4 | ANP | V-type ATP synthase alpha chain | / | 0.454 | |
4q72 | FAD | Bifunctional protein PutA | / | 0.453 | |
3cib | 314 | Beta-secretase 1 | 3.4.23.46 | 0.452 | |
1q0r | AKT | Aclacinomycin methylesterase RdmC | 3.1.1.95 | 0.451 | |
3cic | 316 | Beta-secretase 1 | 3.4.23.46 | 0.451 | |
3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.451 | |
3njo | PYV | Abscisic acid receptor PYR1 | / | 0.451 | |
1f17 | NAI | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.450 | |
1rf9 | DBR | Camphor 5-monooxygenase | 1.14.15.1 | 0.450 | |
1xs7 | MMI | Beta-secretase 1 | 3.4.23.46 | 0.450 | |
4nkv | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.450 | |
4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.450 | |
1jip | KTN | 6-deoxyerythronolide B hydroxylase | / | 0.449 | |
2e9a | B28 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.449 | |
1a72 | PAD | Alcohol dehydrogenase E chain | 1.1.1.1 | 0.448 | |
2bxq | IMN | Serum albumin | / | 0.448 | |
3hdh | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.448 | |
3p6n | DSO | Camphor 5-monooxygenase | 1.14.15.1 | 0.448 | |
5cpb | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.448 | |
1ppj | ANY | Cytochrome b | / | 0.447 | |
1q0z | AKA | Aclacinomycin methylesterase RdmC | 3.1.1.95 | 0.447 | |
2hdh | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.447 | |
2p15 | EZT | Estrogen receptor | / | 0.447 | |
3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.447 | |
3c1t | MYC | Dihydroflavonol 4-reductase | 1.1.1.219 | 0.447 | |
3gyu | DL7 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.447 | |
4klr | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.447 | |
2b37 | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.446 | |
2bxo | OPB | Serum albumin | / | 0.446 | |
2gjl | FMN | Nitronate monooxygenase | 1.13.12.16 | 0.446 | |
2hwr | DRD | Peroxisome proliferator-activated receptor gamma | / | 0.446 | |
2j14 | GNI | Peroxisome proliferator-activated receptor delta | / | 0.446 | |
2wpw | ACO | Orf14 | / | 0.446 | |
2x23 | TCU | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.446 | |
3b9l | AZZ | Serum albumin | / | 0.446 | |
3hcr | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.446 | |
3c3d | FO1 | 2-phospho-L-lactate transferase | / | 0.445 | |
1fml | RTL | Retinol dehydratase | / | 0.444 | |
1osv | CHC | Bile acid receptor | / | 0.444 | |
2qd4 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.444 | |
3bxx | QUE | Dihydroflavonol 4-reductase | 1.1.1.219 | 0.444 | |
3i1f | GCP | Translation initiation factor 2 subunit gamma | / | 0.444 | |
3ipu | O40 | Oxysterols receptor LXR-alpha | / | 0.444 | |
3p9t | TCL | Repressor | / | 0.444 | |
3w5p | 4OA | Vitamin D3 receptor | / | 0.444 | |
4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.444 | |
4jvn | YUG | Estrogen sulfotransferase | 2.8.2.4 | 0.443 | |
5doz | NDP | JamJ | / | 0.443 | |
1pkf | EPD | Epothilone C/D epoxidase | 1.14 | 0.442 | |
1y60 | H4M | 5,6,7,8-tetrahydromethanopterin hydro-lyase | 4.2.1.147 | 0.442 | |
2wo7 | ASV | Isopenicillin N synthase | 1.21.3.1 | 0.442 | |
3irn | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.442 | |
3te4 | ACO | Dopamine N-acetyltransferase | / | 0.442 | |
3wiy | LC6 | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.442 | |
1m78 | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
1phg | MYT | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
2y60 | M8F | Isopenicillin N synthase | 1.21.3.1 | 0.441 | |
4at0 | FAD | Possible succinate dehydrogenase | / | 0.441 | |
4o70 | 1QK | Bromodomain-containing protein 4 | / | 0.441 | |
4uhr | NGI | Adenosine receptor A2a | / | 0.441 | |
2h9i | EAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.440 | |
2p83 | MR0 | Beta-secretase 1 | 3.4.23.46 | 0.440 | |
2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.440 | |
3a3y | OBN | Sodium/potassium-transporting ATPase subunit alpha | / | 0.440 | |
3nx4 | NAP | Putative oxidoreductase | / | 0.440 | |
3oaf | OAG | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
3qlh | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.440 | |
3tda | PN0 | Cytochrome P450 2D6 | / | 0.440 | |
4n82 | FMN | Ribonucleotide reductase (NrdI family protein), putative | / | 0.440 |